Depression is a disorder with high prevalence in primary health care and a significant burden of illness. The delivery of health care for depression, as well as other chronic illnesses, has been criticized for several reasons and new strategies to address the needs of these illnesses have been advocated. Case...
The incentives, value, and leadership components evaluate and implement strategies for financing and sustaining use of clinical best practices despite barriers created by economic and organizational structures that fragment behavioral and general health care. The paper outlines that a challenge for policymakers is how to link depression care with the...
Depression among mothers in the months after delivery has surfaced as an important maternal and child health concern. This paper presents data from three states which indicate that nearly 12% of women reported being moderately depressed after they delivered their baby, and 6% reported being very depressed after delivery. In...
Depression is among the most disabling and costly illnesses in the world. Despite good short-term efficacy outcomes in the treatment of depression, long-term outcomes remain disappointing. This article examines the substantial psychiatric, medical, functional, and economic costs associated with not achieving remission. Available pharmacoeconomic data and randomized, controlled clinical trials...
Almost everyone agrees that depression is a disease that endangers millions of lives and livelihoods. It also costs businesses billions of dollars each year. But what should business do about its treatment? One approach which is favored is "talk therapy" and medication with antidepressants, while the other relies on treatment...
The American Association of Health Plans' AAHP publication, Current Issues Report: Approaches to Depression Care, illustrates that the member health plans are applying the hallmarks mentioned above?with equal success?in the area of behavioral health, specifically depression. This publication, Ten Key Questions, is based on that work. Across the nation, health...
The report highlights health plan's thoughtful and wide-ranging approaches to this common disease, which affects approximately ten percent of the U.S. population at any given time. Because health plans provide the health care for most Americans, (approx. 68% of the population), they have a strong commitment to improve the recognition,...
Correlation with Animal Studies Demonstrates AMPAKINE Compounds Can Prevent Opiate-Induced Respiratory Depression IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR) reported that top-line data from its first Phase IIa study in opiate-induced respiratory depression RD demonstrated that a single oral dose of 2100mg of AMPAKINE[R] CX717 achieved statistical...
Of the estimated 4.3 million women giving birth in the U.S. this year, as many as 650,000 of them will suffer from some form of postpartum depression. Yet, less than 40% of women will be diagnosed and less than 15% will receive treatment. Matria is hoping to change that with...
Presentation to be given at the Bank of Montreal's Focus on Healthcare Conference on August 5-6, 2008 IRVINE, Calif. -- Cortex Pharmaceuticals, Inc. (AMEX: COR, http://www.cortexpharm.com) Chairman, President and CEO, Roger G. Stoll, PhD, will speak at the Bank of Montreal's Focus on Healthcare Conference taking place August...
AURORA, Colo., July 31 /PRNewswire/ -- Sierra Neuropharmaceuticals, Inc., a formulator of pharmaceuticals for direct-to-the-brain treatment of neurological diseases, announced a $21.5-million venture capital Series A financing. Co-leads in the funding were HealthCare Ventures, Morgenthaler Ventures, and Sequel Venture Partners. Other investors include High Country Venture and GC&H Investments...
SEATTLE, July 8 /PRNewswire/ -- The healthcare of one-fourth of all managed Medicaid recipients in the U.S. is being supported with clinical guidelines from Milliman Care Guidelines LLC, A Milliman Company. Based on Milliman records and information from the 2007 Managed Medicare and Medicaid...
PlatformQ, in collaboration with its CME partnerJohns Hopkins, is pleased to announce CardioCareLive , thefirst-of-its-kind, all-virtual event for healthcare professionals dedicatedto the management of patients with multiple cardiometabolic risk factors.Thetwo-day, online-only conference will be held LIVE over the Web: September16-17, 2008. CardioCareLive will feature a dedicated CME...
Hybrid Model of Care Spurs Growth, Keeping Physician Practices Viable and Offering Options for All Patients ROCKVILLE CENTRE, N.Y. -- Concierge Choice Physicians[TM] CCP, the largest national company offering a "hybrid" model of concierge medicine, today announced its expansion into three new states. Physicians in...
Three new products coming soon to Bioniche's growing line of injectable products LAKE FOREST, Ill., July 2 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the acquisition of Baxter Healthcare Corporation's ENLON product line, including: --...
INDIANAPOLIS, July 1 /PRNewswire/ -- CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced it closed a $25 million Series B financing. New investor Care Capital led the round, which included previous investors Pappas Ventures, Domain Associates, Pearl Street...
WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of...
The following consultation report is based on a real clinical dilemma that led to a request for an ethics consultation. Some details have been changed to preserve patient privacy. The goal of this column is to address ethical dilemmas faced by patients, families and healthcare professionals, offering careful analysis...
[ILLUSTRATIONS OMITTED] In 1948, the UK became the first country in the world to offer a free healthcare service to its people. As its founder health minister Aneurin Bevan stated: 'On July 5th, there is no reason why the whole of the doctor-patient relationship should...
Pioneer in Centralized Psychiatric Patient Evaluation for Clinical Trials Expanding Into New Areas of Drug Development HAMILTON, N.J., July 1 /PRNewswire/ -- MedAvante, Inc., the leader in centralized psychiatric patient evaluation, announced today that it has closed a $20 million financing by Goldman, Sachs...
Articles 2008-07-01
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
Innovative USB Sleep'n Charge. Stylish Fusion™ finish. Ultra-portable. It's clear why the Satellite® U405 is a smart choice for you and your small business. Only from the laptop expert, Toshiba.
